echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > JCO: Prognosis of children with adrenocortical carcinoma of different stages treated with various regimens

    JCO: Prognosis of children with adrenocortical carcinoma of different stages treated with various regimens

    • Last Update: 2021-04-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Adrenocortical carcinoma (ACC) is a rare aggressive childhood malignant tumor with unique biological characteristics.


    child

    A prospective single-arm risk-stratification intervention study published recently in " J Clin Oncol " outlines (1) the prognosis of stage I ACC patients undergoing adrenalectomy alone, (2) adrenalectomy and retroperitoneal lymph nodes The prognosis of dissected stage II patients (complete resection >200 cc or >100 g), (3) the prognosis of stage III or IV patients receiving mitotane and chemotherapy.


    J Clin Oncol J Clin Oncol

    EFS and OS in patients of different stages

    EFS and OS in patients of different stages

    From September 2006 to May 2013, a total of 78 patients (77 eligible, 51 women) were enrolled.


    The estimated 5-year event-free survival rates for patients with stage I (24 cases), stage II (15 cases), stage III (24 cases), and stage IV (14 cases) were 86.


    In univariate analysis, age, stage, virilization, Cushing’s syndrome or hypertension, germline TP53 status, and the presence of somatic ATRX mutations are associated with prognosis

    In summary, the surgical treatment of children with stage I ACC has good results.


    Surgical treatment of children with stage I ACC has good results.


    Original source:

    Rodriguez-Galindo Carlos, Krailo Mark D, Pinto Emilia M et al.


    org/10.
    1200/JCO.
    20.
    02871" target="_blank" rel="noopener">Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.